{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:28:22Z","timestamp":1793633302112,"version":"4.5.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100025230","name":"Biotest","doi-asserted-by":"publisher","award":["BT524"],"award-info":[{"award-number":["BT524"]}],"id":[{"id":"10.13039\/501100025230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.thromres.2026.109616","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T07:49:49Z","timestamp":1770709789000},"page":"109616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Efficacy and safety of prophylaxis and treatment of bleeding events with a novel fibrinogen concentrate from human plasma in patients with congenital fibrinogen deficiency"],"prefix":"10.1016","volume":"259","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5584-5049","authenticated-orcid":false,"given":"Claudia Djambas","family":"Khayat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3293-1806","authenticated-orcid":false,"given":"Amal","family":"El-Beshlawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emna Gouider","family":"Belhadjali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0220-3592","authenticated-orcid":false,"given":"Abderrahim","family":"Khelif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Adolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4506-0061","authenticated-orcid":false,"given":"Wolfgang","family":"Miesbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon","family":"Abraha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Schuettrumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7124-4913","authenticated-orcid":false,"given":"Heike","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2026.109616_bb0005","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1160\/TH09-07-0432","article-title":"Why dysfibrinogenaemias still matter","volume":"102","author":"Weisel","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0036-1571342","article-title":"What is the biological and clinical relevance of fibrin?","volume":"42","author":"Litvinov","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1749-6632.2001.tb03525.x","article-title":"Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein","volume":"936","author":"Simpson-Haidaris","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.thromres.2026.109616_bb0020","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ctrv.2015.10.002","article-title":"Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: a systematic review and meta-analysis","volume":"41","author":"Perisanidis","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.thromres.2026.109616_bb0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2018-07-818211","article-title":"The multifaceted role of fibrinogen in tissue injury and inflammation","volume":"133","author":"Luyendyk","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109616_bb0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrn.2018.13","article-title":"Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics","volume":"19","author":"Petersen","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.thromres.2026.109616_bb0035","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00011-024-01916-2","article-title":"The emerging role of fibrin(ogen) in cardiovascular disease","volume":"73","author":"Lan","year":"2024","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.thromres.2026.109616_bb0040","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1055\/s-0036-1579635","article-title":"Fibrinogen is at the interface of host defense and pathogen virulence in Staphylococcus aureus infection","volume":"42","author":"Ko","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0045","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.1240342","article-title":"Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4","volume":"341","author":"Millien","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.thromres.2026.109616_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100793","article-title":"Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management","volume":"48","author":"Casini","year":"2021","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2026.109616_bb0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2019.236901","article-title":"Fibrin(ogen) in human disease: both friend and foe","volume":"105","author":"Vilar","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2026.109616_bb0060","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/bloodadvances.2023012186","article-title":"Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the prospective rare bleeding disorders database","volume":"8","author":"Mohsenian","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2026.109616_bb0065","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","article-title":"Rare bleeding disorders: diagnosis and treatment","volume":"125","author":"Palla","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109616_bb0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1749-6632.1983.tb23232.x","article-title":"Covalent structure of fibrinogen","volume":"408","author":"Henschen","year":"1983","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.thromres.2026.109616_bb0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood.2024025712","article-title":"How I treat quantitative fibrinogen disorders","volume":"145","author":"Casini","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109616_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2001.tb03495.x","article-title":"A database for human fibrinogen variants","volume":"936","author":"Hanss","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.thromres.2026.109616_bb0085","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1055\/s-0038-1673685","article-title":"Mutational epidemiology of congenital fibrinogen disorders","volume":"118","author":"Casini","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MBC.0b013e328331e6db","article-title":"Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects","volume":"21","author":"Miesbach","year":"2010","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2026.109616_bb0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0100","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1538-7836.2006.02014.x","article-title":"Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia","volume":"4","author":"Peyvandi","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0105","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood.2020009472","article-title":"Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia","volume":"137","author":"Casini","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109616_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0044-1788898","article-title":"Clinical, laboratory, and molecular aspects of congenital fibrinogen disorders","volume":"51","author":"Casini","year":"2025","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0030-1248720","article-title":"Fibrinogen and the risk of thrombosis","volume":"36","author":"de Moerloose","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0120","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0029-1225758","article-title":"Congenital fibrinogen disorders","volume":"35","author":"de Moerloose","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000452864","article-title":"Thrombosis in inherited fibrinogen disorders","volume":"44","author":"Korte","year":"2017","journal-title":"Transfus. Med. Hemother."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2026.109616_bb0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2516.2011.02561.x","article-title":"Management of pregnancy, labour and delivery in women with inherited bleeding disorders","volume":"17","author":"Huq","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2026.109616_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.siny.2011.07.006","article-title":"Management of pregnancy and delivery in women with inherited bleeding disorders","volume":"16","author":"Peyvandi","year":"2011","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.thromres.2026.109616_bb0140","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood.2020010116","article-title":"How I treat dysfibrinogenemia","volume":"138","author":"Casini","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109616_bb0145","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MBC.0b013e32832aec2b","article-title":"Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy","volume":"20","author":"Miesbach","year":"2009","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2026.109616_bb0150","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1517\/14712598.8.7.979","article-title":"Treatment of congenital fibrinogen disorders","volume":"8","author":"de Moerloose","year":"2008","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.thromres.2026.109616_bb0155","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0036-1571339","article-title":"Clinical features and management of congenital fibrinogen deficiencies","volume":"42","author":"Casini","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0160","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1538-7836.2011.04424.x","article-title":"Fibrinogen replacement therapy for congenital fibrinogen deficiency","volume":"9","author":"Bornikova","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0165","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2147\/VHRM.S5305","article-title":"Treatment of congenital fibrinogen deficiency: overview and recent findings","volume":"5","author":"Tziomalos","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.thromres.2026.109616_bb0170","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1517\/14712590903193051","article-title":"Fibrinogen concentrate\u2014a potential universal hemostatic agent","volume":"9","author":"Fenger-Eriksen","year":"2009","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.thromres.2026.109616_bb0175","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/01.STR.30.11.2479","article-title":"Recurrent spontaneous intracerebral hemorrhage in a congenitally afibrinogenemic patient: diagnostic pitfalls and therapeutic options","volume":"30","author":"Henselmans","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2026.109616_bb0180","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1538-7836.2009.03633.x","article-title":"Pharmacokinetics and safety of fibrinogen concentrate","volume":"7","author":"Manco-Johnson","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0185","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/rth2.12433","article-title":"Fibrinogen concentrate for bleeding in patients with congenital fibrinogen deficiency: observational study of efficacy and safety for prophylaxis and treatment","volume":"4","author":"Lasky","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0190","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/jth.14392","article-title":"Clinical pharmacology, efficacy and safety study of a triple-secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency","volume":"17","author":"Djambas Khayat","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/hae.14230","article-title":"Efficacy and safety of fibrinogen concentrate for on-demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiency","volume":"27","author":"Djambas Khayat","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2026.109616_bb0200","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/hae.14619","article-title":"Analysis of fibrinogen concentrate pharmacokinetics and dosing for bleeds and surgery in adults, adolescents, and children with congenital afibrinogenaemia and hypofibrinogenaemia","volume":"28","author":"Djambas Khayat","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2026.109616_bb0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/jth.13923","article-title":"Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency","volume":"16","author":"Ross","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0210","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/trf.14421","article-title":"Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial","volume":"58","author":"Lissitchkov","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.thromres.2026.109616_bb0215","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/jth.14727","article-title":"Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients","volume":"18","author":"Lissitchkov","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0220","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/trf.17029","article-title":"Efficacy and safety of fibrinogen concentrate for perioperative prophylaxis of bleeding in adult, adolescent, and pediatric patients with congenital fibrinogen deficiency: FORMA-02 and FORMA-04 clinical trials","volume":"62","author":"Khayat","year":"2022","journal-title":"Transfusion"},{"key":"10.1016\/j.thromres.2026.109616_bb0225","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1538-7836.2008.03076.x","article-title":"Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrate","volume":"6","author":"N\u00e9grier","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/bcp.14147","article-title":"Population pharmacokinetics of a triple-secured fibrinogen concentrate administered to afibrinogenaemic patients: observed age- and body weight-related differences and consequences for dose adjustment in children","volume":"86","author":"Bellon","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2026.109616_bb0235","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1055\/s-0040-1710015","article-title":"Pharmacology, efficacy and safety of a triple-secured fibrinogen concentrate in children less than or equal to 12 years with afibrinogenaemia","volume":"120","author":"Djambas Khayat","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0240","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2020.12.026","article-title":"Pharmacokinetics, surrogate efficacy and safety evaluations of a new human plasma-derived fibrinogen concentrate (FIB Grifols) in adult patients with congenital afibrinogenemia","volume":"199","author":"Ross","year":"2021","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2026.109616_bb0245","article-title":"Pharmacokinetics, hemostatic efficacy, and safety of a new human fibrinogen concentrate in adult and pediatric patients with congenital fibrinogen deficiency","author":"Djambas Khayat","year":"2025","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0250","author":"European Medicines Agency"},{"key":"10.1016\/j.thromres.2026.109616_bb0255","first-page":"237","article-title":"Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens","volume":"17","author":"Clauss","year":"1957","journal-title":"Acta Haematol."},{"key":"10.1016\/j.thromres.2026.109616_bb0260","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/j.thromres.2010.09.004","article-title":"Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia","volume":"126","author":"Miesbach","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2026.109616_bb0265","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/MBC.0b013e3283504118","article-title":"Use of objective efficacy criteria for evaluation of von Willebrand factor\/factor VIII concentrates","volume":"23","author":"Kessler","year":"2012","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2026.109616_bb0270","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/hae.13106","article-title":"Efficacy and safety of a VWF\/FVIII concentrate (wilate\u00ae ) in inherited von Willebrand disease patients undergoing surgical procedures","volume":"23","author":"Srivastava","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2026.109616_bb0275","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0033-1349222","article-title":"Congenital fibrinogen disorders: an update","volume":"39","author":"de Moerloose","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0280","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MBC.0000000000001182","article-title":"Pharmacokinetics, efficacy and safety of a novel fibrinogen concentrate in pediatric patients with congenital afibrinogenemia","volume":"34","author":"Khayat","year":"2023","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2026.109616_bb0285","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.sla.0000151794.28392.a6","article-title":"High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan","volume":"241","author":"Ikeda","year":"2005","journal-title":"Ann. Surg."},{"key":"10.1016\/j.thromres.2026.109616_bb0290","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00423-006-0075-z","article-title":"Thrombosis of the splenoportal axis after splenectomy","volume":"391","author":"Romano","year":"2006","journal-title":"Langenbeck's Arch. Surg."},{"key":"10.1016\/j.thromres.2026.109616_bb0295","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/S0265021508003785","article-title":"Postoperative deep venous thrombosis in a woman with congenital afibrinogenaemia treated with fibrinogen concentrates","volume":"25","author":"Haberer","year":"2008","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.thromres.2026.109616_bb0300","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1055\/a-1745-0420","article-title":"Impact of fibrinogen infusion on thrombin generation and fibrin clot structure in patients with inherited afibrinogenemia","volume":"122","author":"Khayat","year":"2022","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0305","doi-asserted-by":"crossref","DOI":"10.1177\/10760296241254106","article-title":"Long-term safety analysis of a fibrinogen concentrate (RiaSTAP\u00ae\/Haemocomplettan\u00ae P)","volume":"30","author":"Rahe-Meyer","year":"2024","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109616_bb0310","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1097\/MPH.0000000000001812","article-title":"Blood, sweat, and fears: a novel mutation associated with anaphylaxis and nonresponse in a patient with afibrinogenemia","volume":"43","author":"Hsieh","year":"2021","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.thromres.2026.109616_bb0315","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0002-9343(61)90057-2","article-title":"Precipitating antifibrinogen antibody appearing after fibrinogen infusions in a patient with congenital afibrinogenemia","volume":"30","author":"de Vries","year":"1961","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2026.109616_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103264","article-title":"Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial","volume":"85","author":"Rahe-Meyer","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.thromres.2026.109616_bb0325","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/vox.12424","article-title":"Post-authorization safety study of Clottafact\u00ae a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study","volume":"111","author":"N\u00e9grier","year":"2016","journal-title":"Vox Sang."}],"updated-by":[{"DOI":"10.1016\/j.thromres.2026.109633","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000}},{"DOI":"10.1016\/j.thromres.2026.109633","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000}}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826000356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826000356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:48:10Z","timestamp":1793630890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":65,"alternative-id":["S0049384826000356"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109616","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of prophylaxis and treatment of bleeding events with a novel fibrinogen concentrate from human plasma in patients with congenital fibrinogen deficiency","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109616"}}